# Optoseeker

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/optoseeker

- Industry: Biotechnology
- Headquarters: Shenzhen, China
- Website: www.optoseeker.com/
- Latest round: Angel (Jun 16, 2025)
- Investors on record: 5

## About

Optoseeker, based in Shenzhen, China, is a biotech company dedicated to enhancing health through innovative biopharmaceuticals and health supplements tailored for various medical conditions.Founded in 2023, Optoseeker specializes in biotechnology solutions aimed at improving health and wellness. The company has engaged in 2 deals, with its most recent deal occurring on June 16, 2025. The firm is based in Shenzhen, China.Optoseeker specializes in advanced biotechnology solutions focused on improving health and wellness through innovative products. The company's core offerings include a range of biopharmaceuticals and health supplements designed to address various medical conditions and enhance overall physical well-being. These products are developed using advanced research and development techniques, ensuring that they meet high standards of efficacy and safety. The target customer base includes healthcare providers, clinics, and consumers seeking effective and reliable health solutions. Geographically, the company's products are distributed in multiple regions, including Asia-Pacific and North America, catering to a diverse clientele that values quality health products.The revenue model of Optoseeker is structured around direct-to-consumer sales and partnerships with healthcare institutions. Transactions generally involve consumers purchasing health supplements directly from the company’s distribution channels or through affiliated retailers. These transactions entail a streamlined purchasing process, where clients have access to a selection of health products, including flagship offerings that reflect the company's commitment to quality. Pricing plans for these products are set to reflect their premium nature while catering to various market segments. The emphasis on customer satisfaction and effective health solutions positions the company favorably in a competitive market.In June 2025, Optoseeker raised an undisclosed amount of Angel+ funding led by returning investor Innoangel Fund, with participation from Lingyi Capital, Nanshan Venture Capital, He Ding Gong Capital, and Shanghai Angel Foundation Technology. This funding will support the development and launch of new products aimed at addressing additional health challenges. The company is also planning to expand its market presence in Europe and North America by the end of 2025, focusing on increasing distribution partnerships and enhancing its product offerings.

## Funding rounds

- Angel, Jun 16, 2025 — Nanshan Venture Capital, Innoangel Fund, Lingyi Capital, He Ding Gong Capital, Shanghai Angel Foundation Technology

## Investors

- Nanshan Venture Capital (https://capitalatlas.ai/funds/nanshan-venture-capital) — Angel
- Innoangel Fund (https://capitalatlas.ai/funds/innoangel-fund) — Angel
- Lingyi Capital (https://capitalatlas.ai/funds/lingyi-capital) — Angel
- He Ding Gong Capital — Angel
- Shanghai Angel Foundation Technology — Angel